Federal Court Blocks Mail-Order Abortion Pills as Legal Fight and Reactions Grow
A federal court has blocked a rule allowing doctors to prescribe abortion pills via telehealth and mail them across state lines, a move that could sharply limit access to medication abortion in states with strict bans, including Texas.
The rule, finalized in 2023, allowed providers in states where abortion is legal to prescribe mifepristone remotely and ship it to patients elsewhere. That approach became a key access point after the Supreme Court overturned Roe v. Wade, enabling states to enforce abortion restrictions.
The court’s decision halts that system, introducing new legal uncertainty for providers and patients who relied on interstate telehealth services.
Subscribe free for daily political analysis they won’t broadcast. Join 110K+ readers →
Advocacy groups supporting abortion access said the ruling could restrict care for patients in states with few or no in-state options, arguing that medication abortion has become a central part of reproductive healthcare nationwide. Opponents of the rule, including anti-abortion organizations, said the policy undermined state authority by allowing providers to bypass local restrictions.
Medication abortion accounts for a majority of U.S. abortions, making access to mifepristone a focal point in ongoing legal battles. The dispute now centers on how federal drug regulation interacts with state abortion laws.
Subscribe free for daily political analysis they won’t broadcast. Join 110K+ readers →